Triaziquone
Overview[edit | edit source]
Triaziquone is a chemotherapeutic agent used in the treatment of certain types of cancer. It belongs to the class of alkylating agents, which work by adding an alkyl group to the DNA of cancer cells, thereby interfering with their ability to multiply.
Mechanism of Action[edit | edit source]
Triaziquone functions as an alkylating agent, which means it forms covalent bonds with the DNA of cancer cells. This process leads to the cross-linking of DNA strands, ultimately inhibiting DNA replication and transcription. The disruption of these critical cellular processes results in the death of rapidly dividing cancer cells.
Clinical Use[edit | edit source]
Triaziquone is primarily used in the treatment of hematological malignancies such as leukemia and lymphoma. Its effectiveness in these conditions is due to its ability to target rapidly dividing cells, a hallmark of cancerous tissues.
Side Effects[edit | edit source]
As with many chemotherapeutic agents, triaziquone can cause a range of side effects. Common side effects include:
- Myelosuppression: A decrease in the production of blood cells, leading to conditions such as anemia, leukopenia, and thrombocytopenia.
- Nausea and vomiting
- Alopecia (hair loss)
- Mucositis: Inflammation of the mucous membranes
Administration[edit | edit source]
Triaziquone is typically administered intravenously under the supervision of a healthcare professional. The dosage and schedule depend on the type of cancer being treated, the stage of the disease, and the patient's overall health.
Pharmacokinetics[edit | edit source]
The pharmacokinetics of triaziquone involve its absorption, distribution, metabolism, and excretion. After administration, it is rapidly distributed throughout the body and undergoes hepatic metabolism. The metabolites are then excreted primarily through the kidneys.
Research and Development[edit | edit source]
Ongoing research is focused on improving the efficacy and reducing the toxicity of triaziquone. Studies are exploring its use in combination with other chemotherapeutic agents and targeted therapies to enhance its anticancer effects.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
